Clinical Trials Browser

Phase 1 × Lymphangioleiomyomatosis × saracatinib × Clear all

NCT02116712 2016-11-30

The Tolerability of Saracatinib in Subjects With Lymphangioleiomyomatosis (LAM) (SLAM-1)

Phase 1 Completed

Lymphangioleiomyomatosis